When an allergic reaction strikes, timing matters—and epinephrine is the first-line treatment for anaphylaxis. Today, there are more ways to deliver epinephrine than ever, from auto-injectors to nasal spray, with additional options being studied. But no matter the delivery method, the message is critical: epinephrine first—and fast.
Joining us is allergist and FAACT Medical Advisory Board member and allergist, Dr. Manisha Relan, who breaks down why using epinephrine promptly matters, what happens when treatment is delayed, and how taking action quickly can impact the course of an allergic reaction.
Resources to keep you in the know:
- Dr. Manisha Relan
- FAACT's What is Anaphylaxis
- FAACT's Signs and Symptoms of Anaphylaxis
- FAACT's Anaphylaxis Treatment and Management
You can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.
Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.
Sponsored by: ARS Pharma
Thanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!
More episodes from "FAACT's Roundtable"
Don't miss an episode of “FAACT's Roundtable” and subscribe to it in the GetPodcast app.
